Biomarkers

Eric Vail, MD, on Next-Generation Sequencing in Oncology
June 26, 2020

The director of Molecular Pathology and assistant professor of Pathology at Cedars-Sinai spoke about the use of NGS testing to match patients with targeted therapy.

FDA Approves Pembrolizumab Monotherapy Based on Biomarker Indication
June 17, 2020

The FDA approved pembrolizumab for the treatment of adult and pediatric patients with unresectable or metastatic tumor mutational burden-high solid tumors.

Understanding Umbrella & Basket Trial Design in Lung Cancer
August 13, 2015

In this interview, Dr. Sumithra J. Mandrekar talks about umbrella versus basket trials in lung cancer.